In endometrial cancer, the downregulation of FOXC1 by miRNA, specifically miRNA 204 and miRNA 495, inhibits cancer cell proliferation and migration [90,91], suggesting that FOXC1 may possibly act as a potential oncogene in endometrial carcinoma [92]. This evidence concerns the gene FOXC1 and cancer.